Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
The Journal of Clinical Investigation
|
July 26, 2008
Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling
Kitty B J M Cleutjens, Birgit C G Faber, Mat Rousch, et al.
Circulation
|
December 21, 2005
Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation
E Lutgens, S P M Lutgens, B C G Faber, et al.
Neurology
|
December 30, 2004
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis
U A Badrising, G M Th Schreuder, M J Giphart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 21, 2007
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study
M P J Garssen, R van Koningsveld, P A van Doorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P Alberti, E Rossi, D R Cornblath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G Cavaletti, D R Cornblath, I S J Merkies, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
D Binda, E K Vanhoutte, G Cavaletti, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
The Journal of Clinical Investigation
|
July 26, 2008
Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling
Kitty B J M Cleutjens, Birgit C G Faber, Mat Rousch, et al.
Circulation
|
December 21, 2005
Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation
E Lutgens, S P M Lutgens, B C G Faber, et al.
Neurology
|
December 30, 2004
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis
U A Badrising, G M Th Schreuder, M J Giphart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 21, 2007
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study
M P J Garssen, R van Koningsveld, P A van Doorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
P Alberti, E Rossi, D R Cornblath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
G Cavaletti, D R Cornblath, I S J Merkies, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
D Binda, E K Vanhoutte, G Cavaletti, et al.
Page
of 5